Syndax Pharmaceuticals (SNDX) Times Interest Earned (2015 - 2026)
Syndax Pharmaceuticals' (SNDX) quarterly Times Interest Earned came in at -$2.9 in Q1 2026, up 72.32% year-on-year from -$1.68 in Q1 2025, and up 58.11% quarter-over-quarter from -$6.92 in Q3 2025.
Syndax Pharmaceuticals (SNDX) Times Interest Earned (2015 - 2026) Analysis & Trends
Syndax Pharmaceuticals' Times Interest Earned history runs 12 years deep, the most recent figure standing at -$2.9 for Q1 2026.
- On a quarterly basis, Times Interest Earned rose 72.32% year-over-year to -$2.9 in Q1 2026; TTM through Mar 2026 was -$7.95, a 70.02% increase from a year earlier, with the FY2025 full-year figure at -$4.8, down 265.56% from the prior year.
- Times Interest Earned grew to -$2.9 in Q1 2026 per SNDX's latest filing, from -$6.92 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$2.9 in Q1 2026 and bottomed at -$3894.7 in Q3 2024.
- The 5-year median for Times Interest Earned is -$71.58 (2022), against an average of -$427.68.
- Across the five-year window, Times Interest Earned plunged 3044.47% in 2024 and surged 99.82% in 2025, its largest moves.
- Year by year, Times Interest Earned stood at -$1025.2 in 2022, then retreated by 20.62% to -$1236.6 in 2023, then soared by 98.4% to -$19.76 in 2024, then surged by 64.98% to -$6.92 in 2025, then surged by 58.11% to -$2.9 in 2026.
- Per Business Quant, the three latest SNDX Times Interest Earned figures stand at -$2.9 (Q1 2026), -$6.92 (Q3 2025), and -$11.27 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Syndax Pharmaceuticals | 1.87 Bn | 1.52 Bn | 53.02 Mn | -2.90 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.90 |
| Sep 30, 2025 | -6.92 |
| Jun 30, 2025 | -11.27 |
| Mar 31, 2025 | -10.47 |
| Dec 31, 2024 | -19.76 |
| Sep 30, 2024 | -3,894.65 |
| Jun 30, 2024 | -90.84 |
| Mar 31, 2024 | -105.18 |
| Dec 31, 2023 | -1,236.59 |
| Sep 30, 2023 | -123.86 |
| Jun 30, 2023 | -86.55 |
| Mar 31, 2023 | -123.70 |
| Dec 31, 2022 | -1,025.20 |
| Sep 30, 2022 | -20.10 |
| Jun 30, 2022 | -28.26 |
| Mar 31, 2022 | -56.62 |
| Dec 31, 2021 | 192.27 |
| Sep 30, 2021 | -30.87 |
| Jun 30, 2021 | -35.23 |
| Mar 31, 2021 | -43.60 |